American Healthcare REIT, Inc. (AHR) AI Stock Analysis

American Healthcare REIT, Inc., a subsidiary of Griffin Capital Company, LLC, was formed through the merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, combined with the acquisition of American Healthcare Investors' operations. The company holds approximately $4.2 billion in gross investment value. Its portfolio spans 19 million square feet across 312 buildings in 36 states and the United Kingdom. Its properties include medical office buildings, senior housing communities, skilled nursing facilities, and integrated senior health campuses. The REIT is managed by a platform of over one hundred professionals who invest in and oversee healthcare real estate assets.

American Healthcare REIT expanded revenue from $1.26B in FY2021 to $2.26B in FY2025, reflecting a 5-year revenue CAGR of 13.8%. Revenue growth moderated to 9.1% in FY2025, down from 11.4% in FY2024 and 14.9% in FY2023. Gross margin stood at 20.6% in FY2025, while operating margin reached 7.5%. After net losses of -$47.8M in FY2021, -$81.3M in FY2022, -$71.5M in FY2023, and -$37.8M in FY2024, the company recorded net income of $69.8M in FY2025, or EPS of $1.26. Over the trailing twelve months ended June 30, 2026, revenue reached $2.50B, with operating margin at 6.8% and net profit margin at 4.8%. In the quarter ended June 30, 2026, quarterly revenue grew 24.7% year-over-year and quarterly earnings grew 157.5%.

As of June 30, 2026, the company held $156.9M in cash and short-term investments alongside total debt of $1.57B, resulting in net debt of $1.41B. Shareholders' equity was $3.69B against total assets of $5.70B, with a debt-to-equity ratio of 0.42 and a current ratio of 0.18. In FY2025, operating cash flow reached $294.4M and free cash flow was $165.9M. Capital allocation in FY2025 included capital expenditures of $128.6M, dividends paid of $163.5M, and share issuance of $238,000.

AHR trades at a trailing P/E of 79.4x and a forward P/E of 48.1x, higher than the median of its US-listed Real Estate peers at 21.6x and 23.5x, respectively. Its enterprise value of $12.68B corresponds to an EV/EBITDA of 27.8x, compared to the peer median of 14.7x, while its price-to-sales ratio is 4.6x against the peer median of 3.7x. Over the past year, AHR returned 27.9%, outperforming the S&P 500's return of 16.8%.

AHR provides a forward annual dividend of $1.00 per share, representing a dividend yield of 1.88% based on its last close of $53.23. The dividend is paid quarterly with a payout ratio of 70.9%, and the company has paid dividends for 3 consecutive years. Its last ex-dividend date was September 30, 2026.

Wall Street coverage includes 10 Strong Buy and 6 Buy recommendations, with no Hold, Sell, or Strong Sell ratings. The mean price target is $63.69, which is 19.6% above the last close of $53.23. Consensus estimates project FY2026 revenue of $2.81B and EPS of $0.62. For FY2027, the single reporting analyst expects revenue of $3.29B and EPS of $0.99. The company beat EPS estimates in 2 of the last 4 quarters, and the next earnings date is November 5, 2026.

This page is an AI-written research summary of American Healthcare REIT, Inc. (AHR). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: AHR income statement, AHR balance sheet, AHR key metrics, AHR analyst forecast, AHR chart. See the AHR stock overview for the latest quote and news.